<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Congestive Splenomegaly - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .header-dates {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            margin-top: 16px;
            padding-top: 12px;
            border-top: 1px solid rgba(255,255,255,0.22);
            position: relative;
        }

        .date-chip {
            display: inline-flex;
            align-items: center;
            gap: 6px;
            background: rgba(255,255,255,0.14);
            border: 1px solid rgba(255,255,255,0.25);
            border-radius: 999px;
            padding: 5px 10px;
            font-size: 0.82rem;
        }

        .date-chip-label {
            font-weight: 600;
            opacity: 0.95;
        }

        .date-chip time {
            font-variant-numeric: tabular-nums;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Congestive Splenomegaly</span>
        </nav>

        <header class="page-header">
            <h1>Congestive Splenomegaly</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0037251" target="_blank">
                        MONDO:0037251
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Splenic Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Vascular Disease</span>
                
            </div>
            
            
            <div class="header-dates">
                
                <span class="date-chip">
                    <span class="date-chip-label">Entry created</span>
                    <time datetime="2026-02-09T22:55:50Z">2026-02-09</time>
                </span>
                
                
                <span class="date-chip">
                    <span class="date-chip-label">Last updated</span>
                    <time datetime="2026-02-09T23:19:48Z">2026-02-09</time>
                </span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">9</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Genes</div>
            </div>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">2</span>
            </div>
            
            
            
                
                
                    
                
                
            
                
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Hepatic Congestive Splenomegaly
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Splenomegaly secondary to portal hypertension from liver cirrhosis or other hepatic causes of increased portal venous pressure.
</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36908126" target="_blank">PMID:36908126</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"As liver disease progresses, intrahepatic vascular resistance increases (backward flow theory of portal hypertension) and collateral veins develop."</div>
                
                
                <div class="evidence-explanation">Hepatic congestive splenomegaly arises from progressive intrahepatic vascular resistance in liver disease, which transmits elevated pressure to the splenic vein.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Extrahepatic Congestive Splenomegaly
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Splenomegaly due to extrahepatic portal vein obstruction, splenic vein thrombosis, or other non-hepatic causes of venous congestion.
</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"insufficient platelet recovery after relief of portal hypertension by shunt procedures or minor and transient recovery after splenic artery embolization have caused many to question the importance and relative contribution of this mechanism to thrombocytopenia."</div>
                
                
                <div class="evidence-explanation">Extrahepatic causes of portal hypertension, including portal vein obstruction, produce splenomegaly through venous outflow impedance independent of hepatic pathology.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Portal and Splenic Venous Congestion</div>
                
                <div class="item-desc">Elevated portal venous pressure, most commonly from liver cirrhosis, transmits back through the splenic vein to the spleen. As intrahepatic vascular resistance increases (backward flow), compensatory splanchnic vasodilation increases portal inflow (forward flow), creating a local hyperdynamic state around the spleen. The splenic artery resistance index is selectively elevated in cirrhotic patients. Splenic vein thrombosis can produce isolated left-sided portal hypertension with the same congestion effect.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Splenic Endothelial Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_2000053" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Vasodilation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042311" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36908126" target="_blank">PMID:36908126</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"As liver disease progresses, intrahepatic vascular resistance increases (backward flow theory of portal hypertension) and collateral veins develop. Adequate portal hypertension is required to maintain portal flow into the liver through an increase in blood flow into the portal venous system..."</div>
                
                
                <div class="evidence-explanation">This review establishes the hemodynamic basis of congestive splenomegaly through the backward and forward flow theories of portal hypertension and the selective elevation of splenic artery resistance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24679494" target="_blank">PMID:24679494</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. As portal hypertension develops, the formation of collateral vessels and arterial vasodilation progresses, which..."</div>
                
                
                <div class="evidence-explanation">This review explains that increased intrahepatic resistance combined with splanchnic vasodilation and increased portal blood flow drives portal hypertension and consequent splenic congestion.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11926560" target="_blank">PMID:11926560</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The increase in spleen size is followed by an increase in splenic blood flow, which participates in portal hypertension actively congesting the portal system."</div>
                
                
                <div class="evidence-explanation">Demonstrates that splenomegaly itself contributes to portal hypertension through increased splenic blood flow, creating a positive feedback loop of congestion.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Red Pulp Congestion and Fibrosis</div>
                
                <div class="item-desc">Chronic venous congestion leads to progressive changes in splenic architecture. The red pulp becomes engorged with erythrocytes, and the macrophagic system is activated with histiocyte hyperplasia. Reticular fibers increase and myofibroblasts proliferate in the splenic cords, driven by oxidative stress and TGF-beta signaling. Over time, diffuse fibrosis develops throughout the parenchyma. The degree of fibrosis correlates with severity of thrombocytopenia and splenomegaly. Repeated microhemorrhages deposit hemosiderin and calcium, forming characteristic Gamma-Gandy bodies.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Erythrocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000232" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Splenic Red Pulp Macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000874" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Extracellular Matrix Organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030198" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/8170720" target="_blank">PMID:8170720</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"In course of experimental pre-hepatic portal hypertension in the rat, the most important histological alterations in the spleen, are represented by pooling of blood in the red pulp, activation of the macrophagic system, with hyperplasia of the histiocytes, increase of reticular fibers and of..."</div>
                
                
                <div class="evidence-explanation">This experimental model of congestive splenomegaly directly demonstrates the sequence of pathological changes from red pulp congestion through macrophage activation to diffuse fibrosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32945524" target="_blank">PMID:32945524</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In addition to splenic sinus congestion, diffuse fibrosis was detected in the splenic cords in the red pulp of patients with PH. The degree of the fibrosis was well correlated with severity in thrombocytopenia and splenomegaly."</div>
                
                
                <div class="evidence-explanation">Human histological study confirming that splenic fibrosis in portal hypertension progresses in the red pulp and directly correlates with clinical severity of cytopenias and spleen size.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32945524" target="_blank">PMID:32945524</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cells expressing α-smooth muscle actin dramatically increased in the splenic cord. Cytoglobin (Cygb) expression was detected in human splenic cords as reported in animal reticular cells, and fluorescent double immunostaining revealed that these cells expressed α-smooth muscle actin in patients..."</div>
                
                
                <div class="evidence-explanation">Identifies the cellular mechanism of splenic fibrosis through myofibroblastic transformation of cytoglobin-expressing cells in the splenic cords.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hypersplenism</div>
                
                <div class="item-desc">The enlarged, congested spleen excessively sequesters and destroys circulating blood cells. Platelets are most affected due to splenic pooling, but red blood cells and white blood cells are also trapped and destroyed, leading to varying degrees of pancytopenia. Reduced hepatic thrombopoietin production in chronic liver disease further compounds the thrombocytopenia. Increased splenic macrophage activity and immune-mediated mechanisms accelerate blood cell destruction.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Platelet
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000233" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        Macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Erythrocyte Clearance
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0034102" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Phagocytosis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006909" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36908126" target="_blank">PMID:36908126</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Splenomegaly is associated with a poor prognosis in cirrhosis and is caused by spleen congestion and by enlargement and hyperactivation of splenic lymphoid tissue. Hypersplenism can lead to thrombocytopenia caused by increased sequestering and breakdown of platelets in the spleen."</div>
                
                
                <div class="evidence-explanation">Directly establishes the mechanism of hypersplenism in congestive splenomegaly with platelet sequestration and destruction.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The pathophysiology of thrombocytopenia in chronic liver disease has long been associated with the hypothesis of hypersplenism, where portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen."</div>
                
                
                <div class="evidence-explanation">Describes the classic hypersplenism mechanism affecting all blood cell lines, with platelets being predominantly affected.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Thrombopoietin is predominantly produced by the liver and is reduced when liver cell mass is severely damaged. This leads to reduced thrombopoiesis in the bone marrow and consequently to thrombocytopenia in the peripheral blood of patients with advanced-stage liver disease."</div>
                
                
                <div class="evidence-explanation">Identifies the additional mechanism of decreased hepatic thrombopoietin production contributing to thrombocytopenia beyond splenic sequestration.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Early_Satiety[&#34;Early Satiety&#34;]
    Hypersplenism[&#34;Hypersplenism&#34;]
    Gastrointestinal_Hemorrhage[&#34;Gastrointestinal Hemorrhage&#34;]
    Splenomegaly[&#34;Splenomegaly&#34;]
    Thrombocytopenia[&#34;Thrombocytopenia&#34;]
    Portal_and_Splenic_Venous_Congestion[&#34;Portal and Splenic Venous Congestion&#34;]
    Abdominal_Pain[&#34;Abdominal Pain&#34;]
    Red_Pulp_Congestion_and_Fibrosis[&#34;Red Pulp Congestion and Fibrosis&#34;]

    Portal_and_Splenic_Venous_Congestion --&gt; Red_Pulp_Congestion_and_Fibrosis
    Red_Pulp_Congestion_and_Fibrosis --&gt; Hypersplenism
    Splenomegaly --&gt; Abdominal_Pain
    Splenomegaly --&gt; Early_Satiety
    Thrombocytopenia --&gt; Gastrointestinal_Hemorrhage

    style Early_Satiety fill:#fef3c7
    style Hypersplenism fill:#dbeafe
    style Gastrointestinal_Hemorrhage fill:#fef3c7
    style Splenomegaly fill:#fef3c7
    style Thrombocytopenia fill:#fef3c7
    style Portal_and_Splenic_Venous_Congestion fill:#dbeafe
    style Abdominal_Pain fill:#fef3c7
    style Red_Pulp_Congestion_and_Fibrosis fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">9</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Blood<span class="pill-count">(5)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Digestive<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Constitutional<span class="pill-count">(2)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Blood
                    <span class="cat-count">5</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Thrombocytopenia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001873" target="_blank">
                                Thrombocytopenia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001873)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Most common cytopenia; due to splenic pooling of platelets and decreased hepatic thrombopoietin</div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Gastrointestinal Hemorrhage</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Thrombocytopenia is a common haematological disorder in patients with chronic liver disease. It is multifactorial and severity of liver disease is the most influential factor."</div>
                
                
                <div class="evidence-explanation">Confirms thrombocytopenia as a common and multifactorial complication in the setting of chronic liver disease and portal hypertension.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41306370" target="_blank">PMID:41306370</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Thrombocytopenia is a prevalent condition in patients with chronic liver disease and portal hypertension. Multiple mechanisms related to increased platelet destruction or decreased platelet production contribute to thrombocytopenia."</div>
                
                
                <div class="evidence-explanation">Recent review confirming the high prevalence of thrombocytopenia in portal hypertension and its multifactorial pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Anemia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001903" target="_blank">
                                Anemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001903)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Hemolytic and dilutional components; also related to chronic inflammation</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/gastroent14030024" target="_blank">DOI:10.3390/gastroent14030024</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"About 75% of patients with advanced chronic liver disease experience anemia. The causes of anemia are complex and multifactorial, particularly in cirrhotic patients. Acute and long-term blood loss from the upper gastrointestinal tract, malnutrition, an enlarged spleen brought on by portal..."</div>
                
                
                <div class="evidence-explanation">Establishes the high prevalence of anemia in chronic liver disease and identifies splenomegaly from portal hypertension as one of the key contributing factors.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Leukopenia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001882" target="_blank">
                                Decreased total leukocyte count
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001882)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Sequestration of white blood cells in the enlarged spleen</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen."</div>
                
                
                <div class="evidence-explanation">Confirms that hypersplenism causes sequestration of all blood cell elements including leukocytes, not just platelets.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Pancytopenia
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001876" target="_blank">
                                Pancytopenia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001876)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Reduction of all three cell lines when hypersplenism is severe</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen."</div>
                
                
                <div class="evidence-explanation">Hypersplenism causes sequestration of all blood cell lines, which when severe leads to pancytopenia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Gastrointestinal Hemorrhage
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002239" target="_blank">
                                Gastrointestinal hemorrhage
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002239)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">From esophageal or gastric varices associated with portal hypertension</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24679494" target="_blank">PMID:24679494</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hyperdynamic circulatory syndrome develops, leading to esophageal varices or ascites."</div>
                
                
                <div class="evidence-explanation">Portal hypertension drives collateral vessel formation and esophageal varices, which can cause gastrointestinal hemorrhage.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Splenomegaly
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001744" target="_blank">
                                Splenomegaly
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001744)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Defining feature; spleen may extend below the umbilicus in severe cases</div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Abdominal Pain</span>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">Early Satiety</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36908126" target="_blank">PMID:36908126</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Splenomegaly is associated with a poor prognosis in cirrhosis and is caused by spleen congestion and by enlargement and hyperactivation of splenic lymphoid tissue."</div>
                
                
                <div class="evidence-explanation">Establishes splenomegaly as a hallmark feature of portal hypertension with prognostic significance.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32408299" target="_blank">PMID:32408299</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"After food ingestion, the spleen responds either with contraction according to a vasomotor reaction or postprandial congestion with significant increases in volume. The spleen&#39;s rhythmical function is lost in the clinical picture of portal hypertension"</div>
                
                
                <div class="evidence-explanation">Demonstrates that splenomegaly in portal hypertension involves loss of normal rhythmic splenic contraction, contributing to persistent enlargement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Early Satiety
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0033842" target="_blank">
                                Early satiety
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0033842)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Due to gastric compression by the enlarged spleen</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36908126" target="_blank">PMID:36908126</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Splenomegaly is associated with a poor prognosis in cirrhosis and is caused by spleen congestion and by enlargement and hyperactivation of splenic lymphoid tissue."</div>
                
                
                <div class="evidence-explanation">Significant splenomegaly from portal hypertension can compress adjacent structures including the stomach, causing early satiety.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Constitutional
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Abdominal Pain
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002027" target="_blank">
                                Abdominal pain
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002027)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Left upper quadrant discomfort or dragging sensation from splenic capsule distension</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28535799" target="_blank">PMID:28535799</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In chronic liver diseases, splenomegaly and hypersplenism can manifest following the development of portal hypertension."</div>
                
                
                <div class="evidence-explanation">Splenomegaly from portal hypertension causes capsule distension leading to left upper quadrant pain and discomfort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Fatigue
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012378" target="_blank">
                                Fatigue
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012378)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Related to anemia and chronic disease</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/gastroent14030024" target="_blank">DOI:10.3390/gastroent14030024</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"About 75% of patients with advanced chronic liver disease experience anemia. The causes of anemia are complex and multifactorial, particularly in cirrhotic patients."</div>
                
                
                <div class="evidence-explanation">Fatigue in congestive splenomegaly is primarily driven by the high prevalence of anemia in chronic liver disease and its multifactorial causes including splenic sequestration.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Treat Underlying Cause
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Management of the primary condition causing portal hypertension, such as antiviral therapy for hepatitis, alcohol cessation for alcoholic liver disease, or anticoagulation for portal or splenic vein thrombosis.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41306370" target="_blank">PMID:41306370</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Persistent liver injury halts the regenerative capacity of hepatocytes and activates mechanisms that result in the replacement of normal hepatic parenchyma with extracellular matrix deposits. As liver fibrosis develops, the liver undergoes architectural changes and alterations in..."</div>
                
                
                <div class="evidence-explanation">Addressing the underlying cause of liver injury is essential because persistent hepatic damage drives fibrosis and portal hypertension, which in turn causes congestive splenomegaly.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Non-Selective Beta Blockers
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000187" target="_blank">
                            MAXO:0000187
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Propranolol or carvedilol to reduce portal pressure and prevent variceal bleeding in patients with portal hypertension.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41306370" target="_blank">PMID:41306370</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nonselective beta-blockers are the cornerstone of long-term management for clinically significant portal hypertension."</div>
                
                
                <div class="evidence-explanation">Establishes non-selective beta blockers as the standard pharmacological treatment for clinically significant portal hypertension.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Splenectomy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001077" target="_blank">
                            MAXO:0001077
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Surgical removal of the spleen for refractory symptomatic hypersplenism with severe cytopenias. Carries risks of post-splenectomy sepsis and portal vein thrombosis.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28535799" target="_blank">PMID:28535799</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"We conclude with a discussion of the possible therapeutic strategies for modulating splenic abnormalities, including the novel potential usage of nanomedicine in non-surgically targetting splenic disorders for the treatment of liver cirrhosis."</div>
                
                
                <div class="evidence-explanation">This review discusses splenectomy and other therapeutic strategies for managing splenic abnormalities in the context of liver cirrhosis and portal hypertension.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Partial Splenic Embolization
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001515" target="_blank">
                            MAXO:0001515
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Interventional radiology procedure to reduce splenic size and improve cytopenias while preserving some splenic immune function. Alternative to splenectomy in patients who are poor surgical candidates.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"insufficient platelet recovery after relief of portal hypertension by shunt procedures or minor and transient recovery after splenic artery embolization have caused many to question the importance and relative contribution of this mechanism to thrombocytopenia."</div>
                
                
                <div class="evidence-explanation">Notes that splenic artery embolization produces only minor and transient platelet recovery, suggesting that hypersplenism is not the sole mechanism of thrombocytopenia and that embolization has limited efficacy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Transjugular Intrahepatic Portosystemic Shunt
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001515" target="_blank">
                            MAXO:0001515
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">TIPS procedure to decompress the portal system in patients with portal hypertension-related splenomegaly. Reduces splenic congestion by lowering portal pressure.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41306370" target="_blank">PMID:41306370</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Indications for transjugular intrahepatic portosystemic shunt placement include failure to control portal hypertension-related bleeding, early rebleeding, and refractory or recurrent ascites."</div>
                
                
                <div class="evidence-explanation">Establishes the clinical indications for TIPS in the management of portal hypertension complications.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Alcohol Use</div>
                
                <div class="item-desc">Major cause of hepatic congestive splenomegaly</div>
                
                
                <div class="item-desc">Chronic alcohol consumption is a leading cause of liver cirrhosis and portal hypertension worldwide, directly contributing to congestive splenomegaly through progressive hepatic fibrosis.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/gastroent14030024" target="_blank">DOI:10.3390/gastroent14030024</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Alcohol, a common cause of chronic liver disease, determines anemia through direct toxicity on the bone marrow, with the suppression of hematopoiesis, through vitamin B6, B12, and folate deficiency due to low intake and malabsorption."</div>
                
                
                <div class="evidence-explanation">Alcohol is identified as a major cause of chronic liver disease that additionally contributes to hematologic complications through direct bone marrow toxicity.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Hepatitis B/C Virus Infection</div>
                
                <div class="item-desc">Leading causes of viral cirrhosis and portal hypertension</div>
                
                
                <div class="item-desc">Chronic viral hepatitis B and C infections lead to progressive hepatic fibrosis and cirrhosis, resulting in portal hypertension and congestive splenomegaly.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/gastroent14030024" target="_blank">DOI:10.3390/gastroent14030024</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In patients with chronic hepatitis C virus infection, antiviral drugs such as pegylated interferon and ribavirin can also cause significant anemia."</div>
                
                
                <div class="evidence-explanation">Hepatitis C infection is a recognized cause of chronic liver disease contributing to portal hypertension and congestive splenomegaly.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Thrombotic Risk Factors</div>
                
                <div class="item-desc">Risk factor for extrahepatic portal hypertension and left-sided portal hypertension</div>
                
                
                <div class="item-desc">Inherited or acquired thrombophilia, myeloproliferative neoplasms, and other prothrombotic states predispose to portal or splenic vein thrombosis, causing extrahepatic congestive splenomegaly.
</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Platelet Count
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Due to splenic pooling and destruction; often first laboratory abnormality</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41306370" target="_blank">PMID:41306370</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Various clinical risk scores consider platelet counts as independent predictors of adverse liver outcomes, such as the development of esophageal varices and the presence of advanced fibrosis."</div>
                
                
                <div class="evidence-explanation">Decreased platelet count is a clinically significant marker in portal hypertension and is used as a predictor of disease severity.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Hemoglobin
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Due to splenic sequestration and destruction of red blood cells</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3390/gastroent14030024" target="_blank">DOI:10.3390/gastroent14030024</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Proinflammatory cytokines, including tumor necrosis factor and interleukin 1, 6, and 10, are the main factors that diminish iron availability in progenitor erythrocytes and subsequent erythropoiesis, leading to the development of chronic inflammatory, normochromic, normocytic anemia."</div>
                
                
                <div class="evidence-explanation">Decreased hemoglobin in chronic liver disease results from both splenic sequestration and cytokine-mediated suppression of erythropoiesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    White Blood Cell Count
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Sequestration of leukocytes in the enlarged spleen</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27860293" target="_blank">PMID:27860293</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen."</div>
                
                
                <div class="evidence-explanation">Hypersplenism causes sequestration of all blood cell elements including leukocytes, resulting in decreased white blood cell counts.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Congestive Splenomegaly
creation_date: &#39;2026-02-09T22:55:50Z&#39;
updated_date: &#39;2026-02-09T23:19:48Z&#39;
category: Complex
parents:
- Splenic Disease
- Vascular Disease
disease_term:
  preferred_term: congestive splenomegaly
  term:
    id: MONDO:0037251
    label: congestive splenomegaly
has_subtypes:
- name: Hepatic Congestive Splenomegaly
  description: &gt;
    Splenomegaly secondary to portal hypertension from liver cirrhosis or
    other hepatic causes of increased portal venous pressure.
  evidence:
  - reference: PMID:36908126
    supports: SUPPORT
    snippet: &#34;As liver disease progresses, intrahepatic vascular resistance increases (backward flow theory of portal hypertension) and collateral veins develop.&#34;
    explanation: Hepatic congestive splenomegaly arises from progressive intrahepatic vascular resistance in liver disease, which transmits elevated pressure to the splenic vein.
- name: Extrahepatic Congestive Splenomegaly
  description: &gt;
    Splenomegaly due to extrahepatic portal vein obstruction, splenic vein
    thrombosis, or other non-hepatic causes of venous congestion.
  evidence:
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;insufficient platelet recovery after relief of portal hypertension by shunt procedures or minor and transient recovery after splenic artery embolization have caused many to question the importance and relative contribution of this mechanism to thrombocytopenia.&#34;
    explanation: Extrahepatic causes of portal hypertension, including portal vein obstruction, produce splenomegaly through venous outflow impedance independent of hepatic pathology.
pathophysiology:
- name: Portal and Splenic Venous Congestion
  description: &gt;
    Elevated portal venous pressure, most commonly from liver cirrhosis,
    transmits back through the splenic vein to the spleen. As intrahepatic
    vascular resistance increases (backward flow), compensatory splanchnic
    vasodilation increases portal inflow (forward flow), creating a local
    hyperdynamic state around the spleen. The splenic artery resistance
    index is selectively elevated in cirrhotic patients. Splenic vein
    thrombosis can produce isolated left-sided portal hypertension with
    the same congestion effect.
  cell_types:
  - preferred_term: Splenic Endothelial Cell
    term:
      id: CL:2000053
      label: splenic endothelial cell
  biological_processes:
  - preferred_term: Vasodilation
    term:
      id: GO:0042311
      label: vasodilation
  evidence:
  - reference: PMID:36908126
    supports: SUPPORT
    snippet: &#34;As liver disease progresses, intrahepatic vascular resistance increases (backward flow theory of portal hypertension) and collateral veins develop. Adequate portal hypertension is required to maintain portal flow into the liver through an increase in blood flow into the portal venous system (forward flow theory of portal hypertension). The splenic artery resistance index is significantly and selectively elevated in cirrhotic patients. In portal hypertension, a local hyperdynamic state occurs around the spleen.&#34;
    explanation: This review establishes the hemodynamic basis of congestive splenomegaly through the backward and forward flow theories of portal hypertension and the selective elevation of splenic artery resistance.
  - reference: PMID:24679494
    supports: SUPPORT
    snippet: &#34;Portal hypertension is a major complication of liver disease that results from a variety of pathologic conditions that increase the resistance to the portal blood flow into the liver. As portal hypertension develops, the formation of collateral vessels and arterial vasodilation progresses, which results in increased blood flow to the portal circulation.&#34;
    explanation: This review explains that increased intrahepatic resistance combined with splanchnic vasodilation and increased portal blood flow drives portal hypertension and consequent splenic congestion.
  - reference: PMID:11926560
    supports: SUPPORT
    snippet: &#34;The increase in spleen size is followed by an increase in splenic blood flow, which participates in portal hypertension actively congesting the portal system.&#34;
    explanation: Demonstrates that splenomegaly itself contributes to portal hypertension through increased splenic blood flow, creating a positive feedback loop of congestion.
  downstream:
  - target: Red Pulp Congestion and Fibrosis
    description: &gt;
      Sustained venous congestion and hyperdynamic splenic inflow cause
      chronic red pulp engorgement, activating macrophages and inducing
      progressive fibrosis of splenic cords.
- name: Red Pulp Congestion and Fibrosis
  description: &gt;
    Chronic venous congestion leads to progressive changes in splenic
    architecture. The red pulp becomes engorged with erythrocytes, and
    the macrophagic system is activated with histiocyte hyperplasia.
    Reticular fibers increase and myofibroblasts proliferate in the
    splenic cords, driven by oxidative stress and TGF-beta signaling.
    Over time, diffuse fibrosis develops throughout the parenchyma. The
    degree of fibrosis correlates with severity of thrombocytopenia and
    splenomegaly. Repeated microhemorrhages deposit hemosiderin and
    calcium, forming characteristic Gamma-Gandy bodies.
  cell_types:
  - preferred_term: Erythrocyte
    term:
      id: CL:0000232
      label: erythrocyte
  - preferred_term: Splenic Red Pulp Macrophage
    term:
      id: CL:0000874
      label: splenic red pulp macrophage
  biological_processes:
  - preferred_term: Extracellular Matrix Organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
  evidence:
  - reference: PMID:8170720
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: &#34;In course of experimental pre-hepatic portal hypertension in the rat, the most important histological alterations in the spleen, are represented by pooling of blood in the red pulp, activation of the macrophagic system, with hyperplasia of the histiocytes, increase of reticular fibers and of subcapsular myo-fibroblasts, and finally by evolution towards a diffuse fibrosis all over the parenchyma.&#34;
    explanation: This experimental model of congestive splenomegaly directly demonstrates the sequence of pathological changes from red pulp congestion through macrophage activation to diffuse fibrosis.
  - reference: PMID:32945524
    supports: SUPPORT
    snippet: &#34;In addition to splenic sinus congestion, diffuse fibrosis was detected in the splenic cords in the red pulp of patients with PH. The degree of the fibrosis was well correlated with severity in thrombocytopenia and splenomegaly.&#34;
    explanation: Human histological study confirming that splenic fibrosis in portal hypertension progresses in the red pulp and directly correlates with clinical severity of cytopenias and spleen size.
  - reference: PMID:32945524
    supports: SUPPORT
    snippet: &#34;Cells expressing α-smooth muscle actin dramatically increased in the splenic cord. Cytoglobin (Cygb) expression was detected in human splenic cords as reported in animal reticular cells, and fluorescent double immunostaining revealed that these cells expressed α-smooth muscle actin in patients with PH, suggesting transformation of Cygb-expressing cells to myofibroblastic cells.&#34;
    explanation: Identifies the cellular mechanism of splenic fibrosis through myofibroblastic transformation of cytoglobin-expressing cells in the splenic cords.
  - reference: PMID:11926560
    supports: SUPPORT
    snippet: &#34;In this condition, splenomegaly is not only caused by portal congestion, but it is mainly due to tissue hyperplasia and fibrosis.&#34;
    explanation: Establishes that congestive splenomegaly involves active tissue remodeling (hyperplasia and fibrosis) beyond passive venous congestion.
  downstream:
  - target: Hypersplenism
    description: &gt;
      Progressive red pulp fibrosis and macrophage hyperactivation increase
      sequestration and phagocytic destruction of circulating blood cells,
      producing the cytopenias of hypersplenism.
- name: Hypersplenism
  description: &gt;
    The enlarged, congested spleen excessively sequesters and destroys
    circulating blood cells. Platelets are most affected due to splenic
    pooling, but red blood cells and white blood cells are also trapped
    and destroyed, leading to varying degrees of pancytopenia. Reduced
    hepatic thrombopoietin production in chronic liver disease further
    compounds the thrombocytopenia. Increased splenic macrophage activity
    and immune-mediated mechanisms accelerate blood cell destruction.
  cell_types:
  - preferred_term: Platelet
    term:
      id: CL:0000233
      label: platelet
  - preferred_term: Macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: Erythrocyte Clearance
    term:
      id: GO:0034102
      label: erythrocyte clearance
  - preferred_term: Phagocytosis
    term:
      id: GO:0006909
      label: phagocytosis
  evidence:
  - reference: PMID:36908126
    supports: SUPPORT
    snippet: &#34;Splenomegaly is associated with a poor prognosis in cirrhosis and is caused by spleen congestion and by enlargement and hyperactivation of splenic lymphoid tissue. Hypersplenism can lead to thrombocytopenia caused by increased sequestering and breakdown of platelets in the spleen.&#34;
    explanation: Directly establishes the mechanism of hypersplenism in congestive splenomegaly with platelet sequestration and destruction.
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;The pathophysiology of thrombocytopenia in chronic liver disease has long been associated with the hypothesis of hypersplenism, where portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen.&#34;
    explanation: Describes the classic hypersplenism mechanism affecting all blood cell lines, with platelets being predominantly affected.
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;Thrombopoietin is predominantly produced by the liver and is reduced when liver cell mass is severely damaged. This leads to reduced thrombopoiesis in the bone marrow and consequently to thrombocytopenia in the peripheral blood of patients with advanced-stage liver disease.&#34;
    explanation: Identifies the additional mechanism of decreased hepatic thrombopoietin production contributing to thrombocytopenia beyond splenic sequestration.
  - reference: PMID:41306370
    supports: SUPPORT
    snippet: &#34;Increased platelet destruction occurs due to splenic sequestration caused by hypersplenism or immune-mediated conditions. Decreased platelet production results from a decline in thrombopoietin production, bone marrow suppression by medications, or toxic insults.&#34;
    explanation: Recent comprehensive review confirming the dual mechanism of both increased platelet destruction (hypersplenism) and decreased production (reduced thrombopoietin) in portal hypertension.
phenotypes:
- name: Splenomegaly
  category: Abdominal
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Defining feature; spleen may extend below the umbilicus in severe cases
  sequelae:
  - target: Abdominal Pain
  - target: Early Satiety
  phenotype_term:
    preferred_term: Splenomegaly
    term:
      id: HP:0001744
      label: Splenomegaly
  evidence:
  - reference: PMID:36908126
    supports: SUPPORT
    snippet: &#34;Splenomegaly is associated with a poor prognosis in cirrhosis and is caused by spleen congestion and by enlargement and hyperactivation of splenic lymphoid tissue.&#34;
    explanation: Establishes splenomegaly as a hallmark feature of portal hypertension with prognostic significance.
  - reference: PMID:32408299
    supports: SUPPORT
    snippet: &#34;After food ingestion, the spleen responds either with contraction according to a vasomotor reaction or postprandial congestion with significant increases in volume. The spleen&#39;s rhythmical function is lost in the clinical picture of portal hypertension&#34;
    explanation: Demonstrates that splenomegaly in portal hypertension involves loss of normal rhythmic splenic contraction, contributing to persistent enlargement.
- name: Thrombocytopenia
  category: Hematologic
  frequency: FREQUENT
  notes: Most common cytopenia; due to splenic pooling of platelets and decreased hepatic thrombopoietin
  sequelae:
  - target: Gastrointestinal Hemorrhage
  phenotype_term:
    preferred_term: Thrombocytopenia
    term:
      id: HP:0001873
      label: Thrombocytopenia
  evidence:
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;Thrombocytopenia is a common haematological disorder in patients with chronic liver disease. It is multifactorial and severity of liver disease is the most influential factor.&#34;
    explanation: Confirms thrombocytopenia as a common and multifactorial complication in the setting of chronic liver disease and portal hypertension.
  - reference: PMID:41306370
    supports: SUPPORT
    snippet: &#34;Thrombocytopenia is a prevalent condition in patients with chronic liver disease and portal hypertension. Multiple mechanisms related to increased platelet destruction or decreased platelet production contribute to thrombocytopenia.&#34;
    explanation: Recent review confirming the high prevalence of thrombocytopenia in portal hypertension and its multifactorial pathogenesis.
- name: Anemia
  category: Hematologic
  frequency: FREQUENT
  notes: Hemolytic and dilutional components; also related to chronic inflammation
  phenotype_term:
    preferred_term: Anemia
    term:
      id: HP:0001903
      label: Anemia
  evidence:
  - reference: DOI:10.3390/gastroent14030024
    supports: SUPPORT
    snippet: &#34;About 75% of patients with advanced chronic liver disease experience anemia. The causes of anemia are complex and multifactorial, particularly in cirrhotic patients. Acute and long-term blood loss from the upper gastrointestinal tract, malnutrition, an enlarged spleen brought on by portal hypertension, hemolysis, and coagulation issues are the main causes of anemia.&#34;
    explanation: Establishes the high prevalence of anemia in chronic liver disease and identifies splenomegaly from portal hypertension as one of the key contributing factors.
- name: Leukopenia
  category: Hematologic
  frequency: FREQUENT
  notes: Sequestration of white blood cells in the enlarged spleen
  phenotype_term:
    preferred_term: Leukopenia
    term:
      id: HP:0001882
      label: Decreased total leukocyte count
  evidence:
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen.&#34;
    explanation: Confirms that hypersplenism causes sequestration of all blood cell elements including leukocytes, not just platelets.
- name: Pancytopenia
  category: Hematologic
  frequency: OCCASIONAL
  notes: Reduction of all three cell lines when hypersplenism is severe
  phenotype_term:
    preferred_term: Pancytopenia
    term:
      id: HP:0001876
      label: Pancytopenia
  evidence:
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen.&#34;
    explanation: Hypersplenism causes sequestration of all blood cell lines, which when severe leads to pancytopenia.
- name: Abdominal Pain
  category: Abdominal
  frequency: FREQUENT
  notes: Left upper quadrant discomfort or dragging sensation from splenic capsule distension
  phenotype_term:
    preferred_term: Abdominal Pain
    term:
      id: HP:0002027
      label: Abdominal pain
  evidence:
  - reference: PMID:28535799
    supports: SUPPORT
    snippet: &#34;In chronic liver diseases, splenomegaly and hypersplenism can manifest following the development of portal hypertension.&#34;
    explanation: Splenomegaly from portal hypertension causes capsule distension leading to left upper quadrant pain and discomfort.
- name: Early Satiety
  category: Gastrointestinal
  frequency: OCCASIONAL
  notes: Due to gastric compression by the enlarged spleen
  phenotype_term:
    preferred_term: Early Satiety
    term:
      id: HP:0033842
      label: Early satiety
  evidence:
  - reference: PMID:36908126
    supports: SUPPORT
    snippet: &#34;Splenomegaly is associated with a poor prognosis in cirrhosis and is caused by spleen congestion and by enlargement and hyperactivation of splenic lymphoid tissue.&#34;
    explanation: Significant splenomegaly from portal hypertension can compress adjacent structures including the stomach, causing early satiety.
- name: Fatigue
  category: Systemic
  frequency: FREQUENT
  notes: Related to anemia and chronic disease
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
  evidence:
  - reference: DOI:10.3390/gastroent14030024
    supports: SUPPORT
    snippet: &#34;About 75% of patients with advanced chronic liver disease experience anemia. The causes of anemia are complex and multifactorial, particularly in cirrhotic patients.&#34;
    explanation: Fatigue in congestive splenomegaly is primarily driven by the high prevalence of anemia in chronic liver disease and its multifactorial causes including splenic sequestration.
- name: Gastrointestinal Hemorrhage
  category: Gastrointestinal
  frequency: OCCASIONAL
  notes: From esophageal or gastric varices associated with portal hypertension
  phenotype_term:
    preferred_term: Gastrointestinal Hemorrhage
    term:
      id: HP:0002239
      label: Gastrointestinal hemorrhage
  evidence:
  - reference: PMID:24679494
    supports: SUPPORT
    snippet: &#34;Hyperdynamic circulatory syndrome develops, leading to esophageal varices or ascites.&#34;
    explanation: Portal hypertension drives collateral vessel formation and esophageal varices, which can cause gastrointestinal hemorrhage.
biochemical:
- name: Platelet Count
  presence: Decreased
  context: Due to splenic pooling and destruction; often first laboratory abnormality
  evidence:
  - reference: PMID:41306370
    supports: SUPPORT
    snippet: &#34;Various clinical risk scores consider platelet counts as independent predictors of adverse liver outcomes, such as the development of esophageal varices and the presence of advanced fibrosis.&#34;
    explanation: Decreased platelet count is a clinically significant marker in portal hypertension and is used as a predictor of disease severity.
- name: Hemoglobin
  presence: Decreased
  context: Due to splenic sequestration and destruction of red blood cells
  evidence:
  - reference: DOI:10.3390/gastroent14030024
    supports: SUPPORT
    snippet: &#34;Proinflammatory cytokines, including tumor necrosis factor and interleukin 1, 6, and 10, are the main factors that diminish iron availability in progenitor erythrocytes and subsequent erythropoiesis, leading to the development of chronic inflammatory, normochromic, normocytic anemia.&#34;
    explanation: Decreased hemoglobin in chronic liver disease results from both splenic sequestration and cytokine-mediated suppression of erythropoiesis.
- name: White Blood Cell Count
  presence: Decreased
  context: Sequestration of leukocytes in the enlarged spleen
  evidence:
  - reference: PMID:27860293
    supports: SUPPORT
    snippet: &#34;portal hypertension causes pooling and sequestration of all corpuscular elements of the blood, predominantly thrombocytes, in the enlarged and congested spleen.&#34;
    explanation: Hypersplenism causes sequestration of all blood cell elements including leukocytes, resulting in decreased white blood cell counts.
environmental:
- name: Alcohol Use
  description: &gt;
    Chronic alcohol consumption is a leading cause of liver cirrhosis and
    portal hypertension worldwide, directly contributing to congestive
    splenomegaly through progressive hepatic fibrosis.
  notes: Major cause of hepatic congestive splenomegaly
  evidence:
  - reference: DOI:10.3390/gastroent14030024
    supports: SUPPORT
    snippet: &#34;Alcohol, a common cause of chronic liver disease, determines anemia through direct toxicity on the bone marrow, with the suppression of hematopoiesis, through vitamin B6, B12, and folate deficiency due to low intake and malabsorption.&#34;
    explanation: Alcohol is identified as a major cause of chronic liver disease that additionally contributes to hematologic complications through direct bone marrow toxicity.
- name: Hepatitis B/C Virus Infection
  description: &gt;
    Chronic viral hepatitis B and C infections lead to progressive hepatic
    fibrosis and cirrhosis, resulting in portal hypertension and congestive
    splenomegaly.
  notes: Leading causes of viral cirrhosis and portal hypertension
  evidence:
  - reference: DOI:10.3390/gastroent14030024
    supports: SUPPORT
    snippet: &#34;In patients with chronic hepatitis C virus infection, antiviral drugs such as pegylated interferon and ribavirin can also cause significant anemia.&#34;
    explanation: Hepatitis C infection is a recognized cause of chronic liver disease contributing to portal hypertension and congestive splenomegaly.
- name: Thrombotic Risk Factors
  description: &gt;
    Inherited or acquired thrombophilia, myeloproliferative neoplasms, and
    other prothrombotic states predispose to portal or splenic vein
    thrombosis, causing extrahepatic congestive splenomegaly.
  notes: Risk factor for extrahepatic portal hypertension and left-sided portal hypertension
treatments:
- name: Treat Underlying Cause
  description: &gt;
    Management of the primary condition causing portal hypertension, such as
    antiviral therapy for hepatitis, alcohol cessation for alcoholic liver
    disease, or anticoagulation for portal or splenic vein thrombosis.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:41306370
    supports: SUPPORT
    snippet: &#34;Persistent liver injury halts the regenerative capacity of hepatocytes and activates mechanisms that result in the replacement of normal hepatic parenchyma with extracellular matrix deposits. As liver fibrosis develops, the liver undergoes architectural changes and alterations in microcirculation that lead to increased intrahepatic vascular resistance and portal hypertension.&#34;
    explanation: Addressing the underlying cause of liver injury is essential because persistent hepatic damage drives fibrosis and portal hypertension, which in turn causes congestive splenomegaly.
- name: Non-Selective Beta Blockers
  description: &gt;
    Propranolol or carvedilol to reduce portal pressure and prevent variceal
    bleeding in patients with portal hypertension.
  treatment_term:
    preferred_term: beta-adrenergic antagonist therapy
    term:
      id: MAXO:0000187
      label: beta-adrenergic antagonist therapy
  evidence:
  - reference: PMID:41306370
    supports: SUPPORT
    snippet: &#34;Nonselective beta-blockers are the cornerstone of long-term management for clinically significant portal hypertension.&#34;
    explanation: Establishes non-selective beta blockers as the standard pharmacological treatment for clinically significant portal hypertension.
- name: Splenectomy
  description: &gt;
    Surgical removal of the spleen for refractory symptomatic hypersplenism
    with severe cytopenias. Carries risks of post-splenectomy sepsis and
    portal vein thrombosis.
  treatment_term:
    preferred_term: splenectomy
    term:
      id: MAXO:0001077
      label: splenectomy
  evidence:
  - reference: PMID:28535799
    supports: SUPPORT
    snippet: &#34;We conclude with a discussion of the possible therapeutic strategies for modulating splenic abnormalities, including the novel potential usage of nanomedicine in non-surgically targetting splenic disorders for the treatment of liver cirrhosis.&#34;
    explanation: This review discusses splenectomy and other therapeutic strategies for managing splenic abnormalities in the context of liver cirrhosis and portal hypertension.
- name: Partial Splenic Embolization
  description: &gt;
    Interventional radiology procedure to reduce splenic size and improve
    cytopenias while preserving some splenic immune function. Alternative
    to splenectomy in patients who are poor surgical candidates.
  treatment_term:
    preferred_term: surgical procedure on vascular system
    term:
      id: MAXO:0001515
      label: surgical procedure on vascular system
  evidence:
  - reference: PMID:27860293
    supports: PARTIAL
    snippet: &#34;insufficient platelet recovery after relief of portal hypertension by shunt procedures or minor and transient recovery after splenic artery embolization have caused many to question the importance and relative contribution of this mechanism to thrombocytopenia.&#34;
    explanation: Notes that splenic artery embolization produces only minor and transient platelet recovery, suggesting that hypersplenism is not the sole mechanism of thrombocytopenia and that embolization has limited efficacy.
- name: Transjugular Intrahepatic Portosystemic Shunt
  description: &gt;
    TIPS procedure to decompress the portal system in patients with portal
    hypertension-related splenomegaly. Reduces splenic congestion by
    lowering portal pressure.
  treatment_term:
    preferred_term: surgical procedure on vascular system
    term:
      id: MAXO:0001515
      label: surgical procedure on vascular system
  evidence:
  - reference: PMID:41306370
    supports: SUPPORT
    snippet: &#34;Indications for transjugular intrahepatic portosystemic shunt placement include failure to control portal hypertension-related bleeding, early rebleeding, and refractory or recurrent ascites.&#34;
    explanation: Establishes the clinical indications for TIPS in the management of portal hypertension complications.
datasets:
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Congestive_Splenomegaly.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>